Posts

Showing posts from January, 2024

3 Charts About Medicare Drug Price Negotiations

Image
A look at key elements of the process, what it means for beneficiaries, and the public's views View in browser 3 Charts About Medicare Drug Price Negotiations Under the Inflation Reduction Act, the federal government for the first time will negotiate directly with drug companies to determine the prices that Medicare will pay for certain high expenditure drugs covered under Medicare Part D (starting in 2026) and Part B (starting in 2028). Part D covers retail prescription drugs and Part B covers physician-administered medications.  This new requirement is the culmination of years of

The Latest: Questions I Get About the Standards and Practices for Organizations in an Era of Misinformation and Declining Trust

Image
Plus, Number of States with Restrictions Grew Five-fold Over the Last 18 Months View in browser The Latest January 31, 2024 From Drew Altman: Questions I Get About the Standards & Practices for Organizations in an Era of Misinformation & Declining Trust In a new KFF column, President and CEO Drew Altman explains KFF's role in providing independent, authoritative information, and describes standards and practices to maintain credibility in an era of rampant misinformation.